ResearcherIran University of Medical SciencesNo recent work listed

Maryam Sahlolbei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8575-1273; OpenAlex author ID A5070315440. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper

Papers 1

Evaluation of targetable biomarkers for chimeric antigen receptor T-cell (CAR-T) in the treatment of pancreatic cancer: a systematic review and meta-analysis o… Co-author DOI 10.1080/08830185.2020.1776274 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Giandomenico Roviello · 1 shared paper, 2020 · strength 0.12
- Paper Evaluation of targetable biomarkers for chimeric antigen receptor T-cell (CAR-T) in the treatment of pancreatic cancer:… DOI 10.1080/08830185.2020.1776274 ↗
Zahra Madjd · 1 shared paper, 2020 · strength 0.12
- Paper Evaluation of targetable biomarkers for chimeric antigen receptor T-cell (CAR-T) in the treatment of pancreatic cancer:… DOI 10.1080/08830185.2020.1776274 ↗
Alberto D’Angelo · 1 shared paper, 2020 · strength 0.12
- Paper Evaluation of targetable biomarkers for chimeric antigen receptor T-cell (CAR-T) in the treatment of pancreatic cancer:… DOI 10.1080/08830185.2020.1776274 ↗
Jafar Kiani · 1 shared paper, 2020 · strength 0.12
- Paper Evaluation of targetable biomarkers for chimeric antigen receptor T-cell (CAR-T) in the treatment of pancreatic cancer:… DOI 10.1080/08830185.2020.1776274 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.